SCHEMBL2770985

SCHEMBL2770985

O=C(O)c1cccc2c1CCc1cccc(I)c1C2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
MAPT P10636 4/20 0.46
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
POLB P06746 2/20 0.40
HSP90AA1 P07900 1/20 0.39
AKR1B1 P15121 1/20 0.39
LIG1 P18858 1/20 0.38
FOLH1 Q04609 1/20 0.38
KDM4E B2RXH2 2/20 0.37
HNF4A P41235 1/20 0.37
GSR P00390 1/20 0.36
MYC P01106 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
THRB P10828 1/20 0.36
MAPK1 P28482 1/20 0.36
RECQL P46063 1/20 0.36
FGFR1 P11362 1/20 0.36
FGFR2 P21802 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768323 0.84 PTPRC (0.43) ALDH1A1MAPTL3MBTL1KDM4EMEN1
SCHEMBL11524733 0.80 AKR1B1 (0.56) ALDH1A1MAPTLMNAL3MBTL1HSP90AA1
SCHEMBL2769114 0.79 AKR1B1 (0.38) ALDH1A1AKR1B1KDM4EFGFR1FGFR2
SCHEMBL24353347 0.78 CES1 (0.61) L3MBTL1MAPK1CES1
SCHEMBL2769982 0.77 TDP2 (0.38) ALDH1A1MAPTLMNAAKR1B1FGFR1
SCHEMBL15330692 0.76 ALDH1A1 (0.50) ALDH1A1MAPTPOLBHSP90AA1KDM4E
SCHEMBL29950657 0.76 ALDH1A1 (0.50) ALDH1A1MAPTPOLBHSP90AA1KDM4E
SCHEMBL31619492 0.72 ALDH1A1 (0.53) ALDH1A1MAPTLMNAL3MBTL1POLB
SCHEMBL31032281 0.71 ALDH1A1 (0.47) ALDH1A1MAPTLMNAL3MBTL1POLB
SCHEMBL569778 0.71 ALDH1A1 (0.47) ALDH1A1MAPTLMNAL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1479670-B1 NOVEL FUSED RING INDAZOLE COMPOUNDS EISAI R&D MAN CO LTD (JP) 2010-04-21 EP disclosed
US-7390797-B2 Fused indazole compounds EISAI CO., LTD. (JP) 2008-06-24 US disclosed
US-20060111419-A1 Novel fused indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-05-25 US disclosed
EP-1479670-A1 NOVEL FUSED RING INDAZOLE COMPOUNDS Eisai Co., Ltd. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111419-A1 Novel fused indazole compounds MAP2K3, MAP3K11, MAP2K2 ALDH1A1 1751/4885MAPT 2110/4885LMNA 2969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.